STOCK TITAN

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

(Neutral)
(Neutral)
Tags
conferences earnings date

Fortrea (Nasdaq: FTRE) will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026.

The company will host a conference call at 8:00 a.m. ET that day; participants should pre-register to receive dial-in details and a unique PIN. A live webcast will be available at investors.fortrea.com, with a replay posted in Events and Presentations after the call.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – FTRE

-1.15%
6 alerts
-1.15% Session close to close
-9.2% Trough in 3 hr 41 min
$981.75M Market Cap
0.0x Rel. Volume

In the Apr 21 session, FTRE declined 1.15%, reflecting a mild negative market reaction. Argus tracked a trough of -9.2% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the schedule for Fortrea’s Q1 2026 results and conference call, continuing it...
Analysis

This announcement sets the schedule for Fortrea’s Q1 2026 results and conference call, continuing its pattern of pre-announcing reporting dates. Investors will likely focus on how upcoming numbers compare with FY 2025 revenue of $2,723.4M, the prior GAAP net loss of $(986.2M), and 2026 guidance of $2,550M–$2,650M revenue and $190M–$220M adjusted EBITDA. The sizeable backlog of $7,728.0M remains a key metric to watch for future visibility.

Key Figures

Q4 2025 revenue: $660.5M FY 2025 revenue: $2,723.4M FY 2025 GAAP net loss: $(986.2M) +5 more
8 metrics
Q4 2025 revenue $660.5M Fourth quarter 2025 results
FY 2025 revenue $2,723.4M Full-year 2025 results
FY 2025 GAAP net loss $(986.2M) Full-year 2025, includes goodwill impairment
Goodwill impairment $797.9M Recorded in H1 2025
Backlog $7,728.0M Trailing-12-month book-to-bill 1.02x
2026 revenue guidance $2,550M–$2,650M Full-year 2026 outlook
2026 adj. EBITDA guide $190M–$220M Full-year 2026 outlook
Conference call time 8:00 a.m. ET Q1 2026 results call on May 5, 2026

Previous Conferences,earnings date Reports

1 past event · Latest: Jan 29 (Neutral)
Same Type Pattern 1 events
Date Event Sentiment 24h Move Catalyst
Jan 29 Earnings date set Neutral +1.9% Announced Q4 and full-year 2025 results date and conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings-date scheduling news saw a modest positive move of 1.91%, hinting that these logistical updates can coincide with a slightly constructive tone.

Recent Company History

Over recent months, Fortrea has combined operational updates with financial milestones. On Jan 29, 2026, it announced the Q4 and full-year 2025 earnings date and call logistics, which preceded formal 2025 results on Feb 26, 2026 detailing revenue of $2,723.4M, a GAAP net loss driven by a large goodwill impairment, and 2026 revenue and EBITDA guidance. The current Q1 2026 earnings-date announcement continues this pattern of structured communication around periodic results.

Key Terms

contract research organization (CRO)
1 terms
contract research organization (CRO) medical
"Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced..."
A contract research organization (CRO) is an outside company that runs scientific and regulatory work for drug, biotech, and medical-device developers—such as running clinical trials, lab testing, and preparing paperwork for regulators. Investors care because CROs affect how quickly and cheaply a product moves toward approval: they’re like specialized contractors whose capacity, expertise, and costs can speed development, reduce risk, and influence sponsors’ spending and timelines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

DURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results.

To participate in the conference call, participants should pre-register via the call registration link. All registrants will receive dial-in details and a unique PIN providing access to the live call. To avoid potential delays, participants are encouraged to join at least 10 minutes prior to the start of the call.

The live webcast can be accessed at investors.fortrea.com. A replay will be available in the Events and Presentations section of the site following the conclusion of the call.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team, operating across approximately 100 countries, is scaled to deliver focused, agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedInX and Bluesky.

Fortrea Contacts

Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com


FAQ

When will Fortrea (FTRE) report first quarter 2026 financial results?

Fortrea will report first quarter 2026 results before the market opens on May 5, 2026. According to the company, the release timing is ahead of the market open to allow investors time to review results prior to the conference call scheduled for 8:00 a.m. ET.

What time is Fortrea's (FTRE) Q1 2026 conference call and how can I join?

The conference call is scheduled for 8:00 a.m. ET on May 5, 2026. According to the company, participants should pre-register via the call registration link to receive dial-in details and a unique PIN for live access to the call.

Where can investors access the Fortrea (FTRE) live webcast and replay?

Investors can access the live webcast at investors.fortrea.com on May 5, 2026. According to the company, a replay will be posted in the Events and Presentations section of the site following the conclusion of the conference call for later review.

Do I need to pre-register for Fortrea's (FTRE) May 5, 2026 conference call?

Yes—participants are asked to pre-register to receive dial-in details and a unique PIN for the live call. According to the company, pre-registration helps ensure timely access and attendees are encouraged to join at least 10 minutes early to avoid delays.

What should participants know before joining Fortrea's (FTRE) Q1 2026 call on May 5?

Participants should pre-register, expect to receive dial-in details and a unique PIN, and join at least 10 minutes early. According to the company, joining early helps avoid technical delays and ensures access to the live call and webcast at 8:00 a.m. ET.